Sunstone Life Science Ventures - European venture capital investment f...

Sunstone. Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science...

Read Sunstone.eu news digest here: view the latest Sunstone articles and content updates right away or get to their most visited pages. Sunstone.eu is not yet rated by Alexa. It seems that Sunstone content is notably popular in Germany, as 43% of all users (2.1K visits per month) come from this country. We haven’t detected security issues or inappropriate content on Sunstone.eu and thus you can safely use it. Sunstone.eu is hosted with Hosting space (Denmark) and its basic language is English.

Content verdict: Safe
Website availability: Live
Language: English
Last check: 1 month ago

163
Visitors daily
489
Pageviews daily
5
Google PR
N/A
Alexa rank

Best pages on Sunstone.eu

Sunstone Life Science Ventures - European venture capital investment firm

Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.
Portfolio Items Archive - Sunstone

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumordirected immunotherapy, and Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotec...
Sunstone

Sunstone Life Science Ventures’ is a European, early-stage investor based in Copenhagen. We invest in opportunities across the Life Science sector, including therapeutics, medical technology and diagn...

Sunstone.eu news digest

1 month

Fund IV company Cardior Pharmaceuticals acquired by Novo Nordisk

Fund IV company Cardior Pharmaceuticals acquired by Novo Nordisk
Cardior is a leader in the discovery and development of therapies that target RNA as a means to prevent, repair and reverse diseases of the heart. The company’s therapeutic approach targets distinctive non-coding RNAs as a platform for addressing root...
2 months

A Sunstone team update

A Sunstone team update
After 17 years as General Partner and co-founder of Sunstone Life Science Ventures and almost 40 years in the life science industry, our colleague Sten Verland will be taking on a part-time role as Venture Partner as of February 1. Sten will continue...
4 months

Sunstone Life Science Ventures divests its holding in Arcoma AB

Sunstone Life Science Ventures divests its holding in Arcoma AB
Sunstone announces that one hundred percent of the holding in Arcoma AB have been sold in a structured block sale.
Sunstone has been a major owner in Arcoma since 2010 and is proud of what the company has achieved in delivering world-class digital radiographic systems. The investment was placed in Sunstone Life Science Venture Funds II established in 2007. The fund...
5 months

Sunstone Life Science Ventures joins EUR 57 Million Series A Investment in Kynex...

Sunstone Life Science Ventures joins EUR 57 Million Series A Investment in Kynexis to Advance Development of Novel Therapeutics for Cognitive Disorders
Sunstone Life Science Ventures (Sunstone), a leading Nordic venture capital firm, is excited to announce its participation in a EUR 57 million Series A funding round for Kynexis B.V., a pioneering biotech company dedicated to advancing treatments for...